Skip to search formSkip to main contentSkip to account menu

Zadaxin

Known as: Zadaxin![TRADE MARK SIGN]!, Zadaxin™ 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objective: To evaluate the efficacy and safety of antibiotic and Zadaxin on the treatment of patients with severe pneumonia… 
2012
2012
Thymosin proteins, originally isolated from fractionation of thymus tissue, represent a class of compounds that we now know are… 
Review
2011
Review
2011
Influenza constitutes a serious problem for healthcare and social services worldwide, owing to its pattern and the severity of… 
2011
2011
Objective To observe the effect of the zadaxin dilution on oral ulcer after chemotherapy. Methods Sixty eight patients who got an… 
2007
2007
The dynamic behaviors of drug zadaxin getting into carbon nanotubes (CNTs) in different water surroundings were investigated by… 
2007
2007
Abstract:  Mouse studies showed a synergy of thymosin α1 (Tα1) and a natural cytokine mixture (IRX‐2) in increasing T lymphocyte… 
2007
2007
We are the first to report the use of thymosin alpha1 to treat cytomegalovirus infection accompanied with acute respiratory… 
2003
2003
OBJECTIVE To analyse the values in prevention of ventilator associated pneumonia in the patient with longer mechanical… 
1999
1999
Zadaxin (thymosin alpha1; Talpha1) is a synthetic 28 amino acid peptide with multiple biological activities primarily directed…